Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study
Top Cited Papers
- 3 May 2021
- journal article
- research article
- Published by Elsevier BV in Clinical Microbiology & Infection
- Vol. 27 (8), 1173.e1-1173.e4
- https://doi.org/10.1016/j.cmi.2021.04.028
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant RecipientsJAMA, 2021
- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination SettingThe New England Journal of Medicine, 2021
- Antibody response to mRNA SARS-CoV-2 vaccine among dialysis patients—a prospective cohort studyNephrology Dialysis Transplantation, 2021
- Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individualsThe Lancet, 2021
- Could mixing COVID vaccines boost immune response?Nature, 2021
- Immunogenicity and Safety of the 9-Valent Human Papillomavirus Vaccine in Solid Organ Transplant Recipients and Adults Infected With Human Immunodeficiency Virus (HIV)Clinical Infectious Diseases, 2020
- Current Knowledge of Vaccinations in Chronic Kidney Disease PatientsInternational Journal of Nephrology and Renovascular Disease, 2020
- Immunosuppression reduction in kidney transplant recipients during bacterial infection—A retrospective studyClinical Transplantation, 2019
- Serologic Vaccination Response after Solid Organ Transplantation: A Systematic ReviewPLOS ONE, 2013
- Decreased Antibody Response to Influenza Vaccination in Kidney Transplant Recipients: A Prospective Cohort StudyAmerican Journal of Kidney Diseases, 2009